Loading stock data…
$70.81+2.58 (+3.79%)
Tempus AI, Inc.
Tempus AI, Inc. in the Healthcare sector is trading at $70.95 with a market capitalization of $9.4B. Wall Street consensus targets $73.56 (18 analysts), implying a +3.7% move over the next 12 months. The stock is currently 27% below its 52-week high of $97.25, remaining 25.1% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $382.49M↑ | $348.12M↓ | $367.21M↑ | $334.21M↑ | $314.63M |
| Gross Profit | $246.50M↑ | $222.04M↓ | $237.71M↑ | $209.94M↑ | $195.04M |
| Operating Income | -$75.91M↑ | -$84.71M↓ | -$61.41M↓ | -$61.00M↑ | -$61.77M |
| Net Income | $5.64M↑ | -$125.92M↓ | -$54.17M↑ | -$79.98M↓ | -$42.84M |
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytic...